| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YMGME.2013.09.009 |
| P698 | PubMed publication ID | 24113686 |
| P50 | author | Júlio César Rocha | Q43136723 |
| P2093 | author name string | M Robert | |
| P Goyens | |||
| A MacDonald | |||
| F Feillet | |||
| M van Rijn | |||
| A M Lammardo | |||
| A Bélanger-Quintana | |||
| H Gokmen Ozel | |||
| K Ahring | |||
| K Dokoupil | |||
| P2860 | cites work | Identification of an intestinal heme transporter | Q28513323 |
| Effectiveness of selenium supplements in a low-selenium area of China | Q28611340 | ||
| Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase | Q30478264 | ||
| Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals | Q30586300 | ||
| Methods of assessment of zinc status in humans: a systematic review | Q33440128 | ||
| Bone metabolism and the muscle-bone relationship in children, adolescents and young adults with phenylketonuria | Q33656707 | ||
| The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease | Q33940891 | ||
| National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000. | Q34388027 | ||
| Investigation of oxidative stress parameters in treated phenylketonuric patients. | Q48347570 | ||
| Deficiency of selenium enhances the K+-induced release of dopamine in the striatum of mice | Q48582222 | ||
| Cross-sectional study of bone metabolism with nutrition in adult classical phenylketonuric patients diagnosed by neonatal screening. | Q51461571 | ||
| Spastic paraparesis after anaesthesia. | Q51473583 | ||
| Vitamin B-6 status of school-aged patients with phenylketonuria. | Q51594317 | ||
| Peak bone mass in patients with phenylketonuria. | Q51762813 | ||
| Haematological findings in children with inborn errors of metabolism. | Q51791098 | ||
| Impact of lipophilic antioxidants and level of antibodies against oxidized low-density lipoprotein in Polish children with phenylketonuria. | Q51855018 | ||
| Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. | Q53252320 | ||
| PKU: High plasma phenylalanine concentrations are associated with increased prevalence of mood swings | Q58212850 | ||
| Plasma zinc, copper, and erythrocyte superoxide dismutase in children with phenylketonuria | Q61766962 | ||
| Evidence that l-Carnitine and Selenium Supplementation Reduces Oxidative Stress in Phenylketonuric Patients | Q63197180 | ||
| Serum-selenium concentrations in patients with maple-syrup-urine disease and phenylketonuria under dieto-therapy | Q67323530 | ||
| Serum selenium levels in individuals on PKU diets | Q67581821 | ||
| Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control | Q68103625 | ||
| Trace element nutrition status and dietary intake of children with phenylketonuria | Q68831422 | ||
| Trace elements nutriture in hyperphenylalaninemic patients. Long-term follow up study | Q69468099 | ||
| Inadequate iron availability as a possible cause of low serum carnitine concentrations in patients with phenylketonuria | Q70168747 | ||
| Potentially life-threatening cardiac dysrhythmia in a child with selenium deficiency and phenylketonuria | Q70264064 | ||
| Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria | Q71583714 | ||
| Vitamin B12 deficiency in adolescents and young adults with phenylketonuria | Q72235253 | ||
| Decreased bone mineral density in children with phenylketonuria | Q72779909 | ||
| Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients | Q73019102 | ||
| Bioavailability in infants of iron from infant cereals: effect of dephytinization | Q73205634 | ||
| Fractures and phenylketonuria | Q73214521 | ||
| Vitamin B12 deficiency in an adult phenylketonuric patient | Q73614097 | ||
| Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet | Q73641271 | ||
| Antioxidant status in hyperphenylalaninemia | Q77368062 | ||
| Lipophilic antioxidants in patients with phenylketonuria | Q78710533 | ||
| Serum vitamin B12 concentrations within reference values do not exclude functional vitamin B12 deficiency in PKU patients of various ages | Q82210201 | ||
| Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil | Q82971643 | ||
| Bioavailability of minerals and trace elements | Q83022982 | ||
| Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU) | Q83120493 | ||
| Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients | Q83387745 | ||
| Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density | Q85009994 | ||
| Folic acid and cancer--where are we today? | Q85961243 | ||
| Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet | Q34428243 | ||
| Improving the bioavailability of nutrients in plant foods at the household level | Q34521484 | ||
| Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States | Q35212964 | ||
| Selenium and iodine intakes and status in New Zealand and Australia | Q35770588 | ||
| Micronutrients in health and disease | Q36586188 | ||
| Coenzyme Q10 in phenylketonuria and mevalonic aciduria | Q36795119 | ||
| Long-term efficacy of 'ready-to-drink' protein substitute in phenylketonuria | Q37594816 | ||
| Oxidative stress in phenylketonuria: what is the evidence? | Q37868451 | ||
| The oxidative stress of zinc deficiency | Q37905619 | ||
| Oxidative stress in phenylketonuric patients | Q37911044 | ||
| Vitamin B12 deficiency and phenylketonuria | Q37913687 | ||
| Nutrition in phenylketonuria | Q37938086 | ||
| Oxidative stress in phenylketonuria: future directions. | Q37960805 | ||
| Antioxidant treatment strategies for hyperphenylalaninemia | Q38105266 | ||
| Main issues in micronutrient supplementation in phenylketonuria | Q38135616 | ||
| The brain selenoproteome: priorities in the hierarchy and different levels of selenium homeostasis in the brain of selenium-deficient rats | Q39885403 | ||
| Selenium bioavailability: current knowledge and future research requirements | Q39895374 | ||
| BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up | Q42860766 | ||
| The choice of biomarkers determines the selenium status in young German vegans and vegetarians | Q42968029 | ||
| The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children | Q43057322 | ||
| Bone development in children and adolescents with PKU. | Q43434969 | ||
| Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation | Q43658363 | ||
| Iron bioavailability and dietary reference values | Q43837147 | ||
| Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria | Q43840591 | ||
| Oxidative stress in a phenylketonuria animal model. | Q43972437 | ||
| Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C. | Q44125023 | ||
| Effect of diet on plasma total antioxidant status in phenylketonuric patients | Q44305237 | ||
| Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria | Q44519974 | ||
| Iron and protein sufficiency and red cell indices in phenylketonuria | Q44620657 | ||
| A longitudinal study of antioxidant status in phenylketonuric patients. | Q44769803 | ||
| The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet | Q44906685 | ||
| Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria | Q45263221 | ||
| Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients. | Q46017779 | ||
| Impact of metabolic control on bone quality in phenylketonuria and mild hyperphenylalaninemia | Q46050032 | ||
| Long-term compliance with a novel vitamin and mineral supplement in older people with PKU. | Q46304638 | ||
| L-carnitine blood levels and oxidative stress in treated phenylketonuric patients | Q46349805 | ||
| Oxidative stress in patients with phenylketonuria. | Q46476925 | ||
| Cognitive functions and the antioxidant system in phenylketonuric patients | Q46510332 | ||
| Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy. | Q46615833 | ||
| Teratogen update: vitamin A congeners | Q47878139 | ||
| Dietary selenium and major depression: a nested case-control study | Q47908272 | ||
| Iron status of children with phenylketonuria undergoing nutrition therapy assessed by transferrin receptors | Q47961350 | ||
| P921 | main subject | phenylketonuria | Q194041 |
| P304 | page(s) | S6-17 | |
| P577 | publication date | 2013-09-19 | |
| P1433 | published in | Molecular Genetics and Metabolism | Q6895949 |
| P1476 | title | Micronutrient status in phenylketonuria | |
| P478 | volume | 110 Suppl |
| Q92959365 | Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients |
| Q27008288 | Bone health in phenylketonuria: a systematic review and meta-analysis |
| Q49500552 | Dietary intervention in the management of phenylketonuria: current perspectives. |
| Q47893508 | Effects of Inadequate Amino Acid Mixture Intake on Nutrient Supply of Adult Patients with Phenylketonuria. |
| Q91715652 | Effects of LC-PUFA Supplementation in Patients with Phenylketonuria: A Systematic Review of Controlled Trials |
| Q41161393 | Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders |
| Q40963267 | Influence of phenylketonuria's diet on dimethylated arginines and methylation cycle. |
| Q37243758 | Lipid profile status and other related factors in patients with Hyperphenylalaninaemia. |
| Q49787227 | Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods. |
| Q40591285 | Micronutrient in hyperphenylalaninemia |
| Q33917049 | Micronutrients, Essential Fatty Acids and Bone Health in Phenylketonuria. |
| Q37198978 | Nutritional status of patients with phenylketonuria in Japan |
| Q26783331 | Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations |
| Q26770291 | Phenylketonuria: a review of current and future treatments |
| Q39819235 | Protein substitutes for phenylketonuria in Europe: access and nutritional composition |
| Q47899947 | Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria |
| Q40181778 | Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile. |
| Q42376686 | The complete European guidelines on phenylketonuria: diagnosis and treatment. |
| Q28072100 | Transdisciplinary approaches enhance the production of translational knowledge |
| Q51283344 | Vitamin and mineral status in patients with hyperphenylalaninemia. |
Search more.